Drug Profile
Research programme: cytoprotection therapy - Onconova
Alternative Names: Ameliorex; Cytoprotection therapy research programme - Onconova; ON 01060; ON 01560; ON 01590; ON 01620Latest Information Update: 23 Feb 2010
Price :
$50
*
At a glance
- Originator Onconova Therapeutics
- Class Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chemotherapy-induced damage
Most Recent Events
- 01 Jul 2004 Preclinical trials in Chemotherapy induced damage (Prevention) in USA (unspecified route)